Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

Clinical trial NCT04516811 · TERMINATED

Trial details

NCT number: NCT04516811
Sponsor: South African National Blood Service
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 SARS-CoV-2 Infection Severe Acute Respiratory Syndrome Coronavirus 2

Start date: 2020-09-21
Primary completion: 2021-12-30
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.